Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationDepreciation & Amortization (IS)Depreciation ExpenseEBIATLeasesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares OutstandingShort-Term Debt issuances
Ratios

Sanara MedTech (SMTI) Depreciation Expense (2018 - 2025)

Historic Depreciation Expense for Sanara MedTech (SMTI) over the last 8 years, with Q3 2025 value amounting to $41557.0.

  • Sanara MedTech's Depreciation Expense fell 6793.24% to $41557.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $768790.0, marking a year-over-year increase of 4806.12%. This contributed to the annual value of $1.0 million for FY2024, which is 12613.49% up from last year.
  • According to the latest figures from Q3 2025, Sanara MedTech's Depreciation Expense is $41557.0, which was down 6793.24% from $45350.0 recorded in Q2 2025.
  • Over the past 5 years, Sanara MedTech's Depreciation Expense peaked at $635625.0 during Q4 2024, and registered a low of $17488.0 during Q1 2021.
  • In the last 5 years, Sanara MedTech's Depreciation Expense had a median value of $106347.0 in 2022 and averaged $118375.3.
  • In the last 5 years, Sanara MedTech's Depreciation Expense soared by 47876.03% in 2022 and then plummeted by 6793.24% in 2025.
  • Over the past 5 years, Sanara MedTech's Depreciation Expense (Quarter) stood at $93123.0 in 2021, then grew by 15.02% to $107114.0 in 2022, then rose by 15.18% to $123376.0 in 2023, then skyrocketed by 415.19% to $635625.0 in 2024, then tumbled by 93.46% to $41557.0 in 2025.
  • Its Depreciation Expense stands at $41557.0 for Q3 2025, versus $45350.0 for Q2 2025 and $46258.0 for Q1 2025.